February 07, 2026 — RNews

#virologic suppression — Saturday, February 07, 2026 (1 items)

hot top new

← prev day next day →

0

Switch to fixed-dose doravirine (100 mg) and islatravir (0.25 mg) once daily in virologically suppressed adults with HIV-1 on oral antiretroviral therapy: 48-week results of a phase 3, multicentre, randomised, open-label, non-inferiority trial. (linkinghub.elsevier.com)

Orkin C … Kim J The Lancet 2026-02-07

#amr #clinical trial #hiv #virologic suppression